Puma Biotechnology Inc (PBYI)
4.89
-0.04
(-0.91%)
USD |
NASDAQ |
May 02, 11:36
Puma Biotechnology 1 Year Total Returns (Daily): 86.93% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | 86.93% |
April 30, 2024 | 89.18% |
April 29, 2024 | 87.31% |
April 26, 2024 | 93.08% |
April 25, 2024 | 79.41% |
April 24, 2024 | 73.74% |
April 23, 2024 | 84.86% |
April 22, 2024 | 86.31% |
April 19, 2024 | 80.87% |
April 18, 2024 | 74.48% |
April 17, 2024 | 72.91% |
April 16, 2024 | 68.87% |
April 15, 2024 | 77.15% |
April 12, 2024 | 81.10% |
April 11, 2024 | 88.66% |
April 10, 2024 | 88.57% |
April 09, 2024 | 93.69% |
April 08, 2024 | 87.04% |
April 05, 2024 | 105.1% |
April 04, 2024 | 95.39% |
April 03, 2024 | 76.57% |
April 02, 2024 | 70.87% |
April 01, 2024 | 70.87% |
March 28, 2024 | 115.4% |
March 27, 2024 | 134.5% |
Date | Value |
---|---|
March 26, 2024 | 153.4% |
March 25, 2024 | 152.9% |
March 22, 2024 | 127.8% |
March 21, 2024 | 113.1% |
March 20, 2024 | 90.08% |
March 19, 2024 | 91.11% |
March 18, 2024 | 107.1% |
March 15, 2024 | 106.6% |
March 14, 2024 | 113.9% |
March 13, 2024 | 113.2% |
March 12, 2024 | 106.6% |
March 11, 2024 | 112.0% |
March 08, 2024 | 89.72% |
March 07, 2024 | 94.92% |
March 06, 2024 | 83.72% |
March 05, 2024 | 61.37% |
March 04, 2024 | 66.98% |
March 01, 2024 | 46.52% |
February 29, 2024 | 61.14% |
February 28, 2024 | 70.98% |
February 27, 2024 | 64.38% |
February 26, 2024 | 63.22% |
February 23, 2024 | 60.54% |
February 22, 2024 | 45.21% |
February 21, 2024 | 55.74% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.08%
Minimum
Oct 18 2019
153.4%
Maximum
Mar 26 2024
-19.70%
Average
-20.50%
Median
Sep 24 2020
1 Year Total Returns (Daily) Benchmarks
ADMA Biologics Inc | 95.03% |
Pfizer Inc | -27.05% |
Sarepta Therapeutics Inc | 4.52% |
Immunogen Inc (DELISTED) | -- |
Regeneron Pharmaceuticals Inc | 11.94% |